Skip to main content
Caplight Logo









Neion Bio

Neion Bio

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.neionbio.com/

Last Round

Series A

Jun 11, 2026

Total Funding Raised

$34M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Neion Bio is a biotechnology company that has developed a biomanufacturing platform using genetically engineered eggs to produce biologic medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Pharma Supply Chain, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

biomanufacturingrecombinant proteinbiologicsbiosimilaregg-based manufacturingmolecular farmingtherapeutic proteinsbiotech platformanimal healthpharma supply chainbioprocessinggenetically engineeredpharma outsourcingcdmo

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neion Bio Comparables

Compare Neion Bio with similar companies based on industry and business-model similarity.

Neion Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
iBio, Inc.
66%
JSR Life Sciences
64%
British American Tobacco
64%

Neion Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 11, 2026
SeedMar 26, 2026

Neion Bio Investors

Notable investors and investment history

Neion Bio investors
InvestorRounds
Clocktower VenturesSeries A, Seed
Digitalis VenturesSeries A
HaystackSeries A, Seed
Hawktail ManagementSeries A
Ensemble VCSeries A
Basis Set VenturesSeries A, Seed
Trust VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open roles increased to 13, 81% of headcount.

  • Jul 28, 2026

    Grew 23% QoQ, from 13 to 16 employees.

Neion Bio Filings

Explore SEC and related filing metadata, where available.

Neion Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Neion Bio's valuation, stock price, and market status.

Is Neion Bio a public or private company?

Neion Bio is a private company.

What is the current stock price of Neion Bio?

Neion Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Neion Bio worth (valuation)?

Valuation information for Neion Bio is not publicly available.

Can I buy Neion Bio stock?

Neion Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Neion Bio's last funding round?

Neion Bio's most recent funding round was Series A on June 11, 2026.

Who are the main investors in Neion Bio?

Key investors in Neion Bio include Caffeinated Capital.

Will Neion Bio IPO soon?

No public IPO plans have been announced for Neion Bio.

How can I track Neion Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neion Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range16
Year Founded2024
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?